SEARCH

SEARCH BY CITATION

References

  • Albasanz J. L., Ros M. and Martin M. (1997) Characterization of metabotropic glutamate recpetors in rat C6 glioma cells. Eur. J. Pharmacol. 326, 8591.DOI: 10.1016/S0014-2999(97)00154-4
  • Anderson C. M. and Swanson R. A. (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 114.DOI: 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.3.CO;2-N
  • Aronica E., Gorter J. A., Ijlst-Keizers H., Rozemuller A. J., Yankaya B., Leenstra S. and Troost D. (2003) Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins. Eur. J. Neurosci. 17, 21062118.DOI: 10.1046/j.1460-9568.2003.02657.x
  • Besong G., Battaglia G., D'Onofrio M. et al. (2002) Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures. J. Neurosci. 22, 54035411.
  • Biber K., Laurie D. J., Berthele A., Sommer B., Tolle T. R., Gebicke-Harter P. J., Van Calker D. and Bodder H. W. (1999) Expression and signaling of group I metaobotropic glutamate receptors in astrocytes and microglia. J. Neurochem. 72, 16711680.
  • Bissonnette B., Pellerin L., Ravussin P., Daven V. B. and Magistretti P. J. (1999) Deep hypothermia and rewarming alters glutamate levels and glycogen content in cultured astrocytes. Anesthesiology 91, 17631769.
  • Boje K. M. (2004) Nitric oxide neurotoxicity in neurodegenerative diseases. Front. Biosci. 9, 763776.
  • Bruno V., Copani A., Battaglia G., Raffaele R., Shinozaki H. and Nicoletti F. (1994) Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death. Eur. J. Pharmacol. 256, 109112.
  • Bruno V., Battaglia G., Copani A., Caciagi F. and Nicoletti F. (1998) Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor- β. J. Neurosci. 18, 95949600.
  • Buisson A. and Choi D. W. (1995) The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death. Neuropharmacology 34, 10811087.
  • Casado M., Bendahan A., Zafra F., Danbolt N. C., Aragon C., Gimenez C. and Kanner B. I. (1993) Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J. Biol. Chem. 268, 27 31327 317.
  • Chen Y. M. and Swanson R. A. (2003) Astrocytes and brain injury. J. Cereb. Blood. Flow Metab. 23, 137149.
  • Chiba K., Trevor A. and Castagnoli N. J. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574578.
  • Copani A., Bruno V., Battaglia G., Leanza G., Pellitteri R., Russo A., Stanzani S. and Nicoletti F. (1995) Activation of metabotropic glutamate receptors protects neurons against apoptosis induced by beta-amyloid peptide. Mol. Pharmacol. 47, 890897.
  • D'Onofrio M., Cuomo L., Battaglia G. et al. (2001) Neuroprotection mediated by glial group –II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. J. Neurochem. 78, 435445.
  • Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1105.
  • Dehmer T., Heneka M. T., Sastre M., Dichgans J. and Schulz J. B. (2004) Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J. Neurochem. 88, 494501.
  • Dowd L. A. and Robinson M. B. (1996) Rapid stimulation of EAAC1-mediated Na+-dependent L-glutamate transport activity in C6 glioma cells by phorbol ester. J. Neurochem. 67, 508516.
  • Frizzo M. E., Lara D. R., Dahm K. C., Prokopiuk A. S., Swanson R. A. and Souza D. O. (2001) Activation of glutamate uptake by guanosine in primary astrocyte cultures. Neuroreport 12, 879881.
  • Gao H. M., Hong J. S., Zhang W. and Liu B. (2002a) Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J. Neurosci. 22, 782790.
  • Gao H. M., Jiang J., Wilson B., Zhang W. Q., Hong J. S. and Liu B. (2002b) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J. Neurochem. 81, 12851297.
  • Gao H. M., Hong J. S., Zhang W. and Liu B. (2003) Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J. Neurosci. 23, 12281236.
  • Hantaz-Ambroise D., Cambier D., Ait-Ikhlef A., Parvy P., Murawsky M. and Rieger F. (1995) Excess extracellular and low intracellular glutamate in poorly differentiating wobbler astrocytes and astrocyte recovery in glutamine-depleted culture medium. J. Neurochem. 65, 11991204.
  • Hazell A. S., Itzhak Y., Liu H. and Norenberg M. D. (1997) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropuridine (MPTP) decreases glutamate uptake in cultured astrocytes. J. Neurochem. 68, 22162219.
  • Hazell A. S., Pannunzio P., Rama Rao K. V., Pow D. V. and Rambaldi A. (2003) Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia 43, 175184.
  • Hirsch E. C. (2000) Glial cells and parkinson's disease. J. Neurol. 247(Suppl. 2), II5862.
  • Hunot S. and Hirsch E. C. (2003) Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 53, s49s60.
  • Janssens N. and Lesage A. S. (2001) Glutamate receptor subunit expression in primary neuronal and secondary glial cultures. J. Neurochem. 77, 14571474.
  • Korcok J., Wu F., Tyml K., Hammond R. R. and. Wilson J. X. (2002) Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxidase synthase induction and glutamate uptake inhibition. J. Neurochem. 81, 185193.
  • Leza J. C., Salas E., Sawicki G. and Russell J. C. and. Radomski M. W. (1998) The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J. Pharmacol. Exp. Ther. 286, 13971403.
  • Liu B., Gao H. M., Wang J. Y., Jeohn G. H., Cooper C. L. and Hong J. S. (2002) Role of nitric oxide in inflammation-mediated neurodegenration. Ann. N.Y. Acad. Sci. 962, 318331.
  • Liu Y., He H. R., Ding J. H., Gu B., Wang H. and Hu G. (2003) Iptkalim inhibits cocaine challenge-induced enhancement of dopamine levels in nucleus accumbens and striatum of rats by up-regulating Kir6.1 and Kir6.2 mRNA expression. Acta Pharmacol. Sin. 24, 527533.
  • Maiese K., Swiriduk M. and TenBroeke M. (1996) Cellular mechanisms of protection by metabotropic glutamate receptors during anoxia and nitric oxide toxicity. J. Neurochem. 66, 24192428.
  • Marino M. J., Valenti O. and Conn P. J. (2003) Glutamate receptors and Parkinson's disease: opportunities for intervention. Drugs Aging 20, 377397.
  • Matarredona E. R., Santiago M., Venero J. L., Cano J. and Machado A. (2001) Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction. J. Neurochem. 76, 351360.
  • Matute C., Alberdi E. and Ibarretxe G. and Sanchez-Gomez M.V. (2002) Excitotoxicity in glial cells. Eur. J. Pharmacol. 447, 239246.
  • McNaught K. S. and Jenner P. (1999) Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures. J. Neurochem. 73, 24692476.
  • McNaught K. S. and Jenner P. (2000a) Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. Biochem. Pharmacol. 60, 979988.
  • McNaught K. S. and Jenner P. (2000b) Dysfunction of rat forebrain astrocytes in culture alters cytokine and neurotrophic factor release. Neurosci. Lett. 285, 6165.
  • Moldrich R. X., Aprico K., Diwakarla S., O'Shea R. D. and Beart P. M. (2002) Astrocyte mGlu (2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures. Neuropharmacology. 43, 189203.
  • Muramatsu Y., Kurosaki R., Watanabe H., Michimata M., Matsubara M., Imai Y. and Araki T. (2003) Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Glia 42, 307313.
  • Palos T. P., Zheng S. and Howard B. D. (1999) Wnt signaling induces GLT-1 expression in rat C6 glioma cells. J. Neurochem. 73, 10121023.
  • Pines G. and Kanner B. I. (1990) Counterflow of L-glutamate in plasma membrane vesicles and reconstituted preparations from rat brain. Biochemistry 29, 11 20911 214.
  • Przedborski S. and Jackson-Lewis V. (1998) Mechamisms of MPTP toxicity. Mov. Disord. 13, 3538.
  • Sagara Y. and Schubert D. (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J. Neurosci. 18, 66626671.
  • Sorg O., Horn T. F., Yu N., Gruol D. L. and Bloom F. E. (1997) Inhibition of astrocyte glutamate uptake by reactive oxygen species: role of antioxidant enzymes. Mol. Med. 3, 431440.
  • Takuma K., Phuagphong P., Lee E., Enomoto R., Mori K., Baba A. and Matsuda T. (2002) The nitric oxide donor NOC12 protects cultured astrocytes against apoptosis via a cGMP-dependent mechanism. Jpn J. Pharmacol. 89, 6471.
  • Takuma K., Baba A. and Matsuda T. (2004) Astrocyte apoptosis: implications for neuroprotection. Prog. Neurobiol. 72, 111127.
  • Taylor D. L., Diemel L. T., Cuzner M. L. and Pocock J. M. (2002) Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J. Neurochem. 82, 11791191.
  • Taylor D. L., Diemel L. T. and Pocock J. M. (2003) Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci. 23, 21502160.
  • Teisman P., Tieu K., Cohen O., Choi D. K., Wu D. C., Marks D., Vila M., Jackson-Lewis V. and Przedborski S. (2003) Pathogenic role of glial cells in Parkinson's disease. Mov. Disord. 18, 121129.
  • Trotti D., Rossi D., Gjesdal O., Levy L. M., Racagni G., Danbolt N. C. and Volterra A. (1996) Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271, 59765979.
  • Trotti D., Danbolt N. C. and Volterra A. (1998) Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19, 328334.
  • Trotti D., Peng J. B., Dunlop J. and Hediger M. A. (2001) Inhibition of the glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters. Brain Res. 914, 196203.
  • Tsai M. J. and Lee E. H. (1998) Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4-phenylpyridinium-induced toxicity. Free Radic. Biol. Med. 24, 705713.
  • Venero J. L., Santiago M., Tomas-Camardiel M., Matarredona E. R., Cano J. and Machado A. (2002) DCG-IV but not other group II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury. Neuroscience 113, 857869.
  • Winder D. G., Ritch P. S., Gereau R. W. and Conn P. J. (1996) Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus. J. Physiol. 494, 743755.
  • Wolosker H., Reis M., Assreuy J. and De Meis L. (1996) Inhibition of glutamate uptake and proton pumping in synaptic vesicles by S-nitrosylation. J. Neurochem. 66, 19431948.
  • Wroblewska B., Santi M. R. and Neale J. H. (1998) N-Acetylaspartylglutamate activates cyclic AMP-coupled metabotropic glutamate receptors in cerebellar astrocytes. Glia 24, 172179.
  • Yao H. H., Ding J. H. and Hu G. (2004) Inhibitory effects of 1-methyl-4-phenylpyridinium on the glutamate uptake into cultured C6 glioma cells. Acta Pharmacol. Sin. 25, 855860.